People are seen inside the First Republic Bank branch in Midtown Manhattan in New York City, New York, U.S., March 13, 2023. REUTERS/Mike Segar Mike Segar | Reuters Check out the companies making the ...
Tag: MRNA
Novavax Says ‘Substantial Doubt’ Around Its Continuing Operations
Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this year. In a quarterly earnings report issued after the market c...
How Much Bear is Left in MRNA Stock? Will it Rebound in March?
Moderna has landed a deal with the US National Institute of Health. MRNA stock fell by 0.71% yesterday. Health-related stocks have surged during the pandemic considering the companies bagging large va...
Moderna Hopes To Build On mRNA Tech Used In Its Covid Shots—By Targeting Genetic Diseases
Topline Moderna on Wednesday announced a new partnership with Life Edit Therapeutics geared towards finding and developing treatments for rare genetic diseases and other conditions, as the Massachuset...
Stocks moving big midday: DE, ABNB, AN, MRNA
Deere’s autonomous 8R tractor Deere Check out the companies making the biggest moves midday: Deere — Shares rose 7.7% after the company reported earnings-per-share of $6.55 for its fiscal first ...
mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds—Though Vaccine Uptake Remains Low
Topline mRNA Covid vaccines, such as Pfizer and Moderna shots, are effective at preventing infection and severe illness and have low rates of serious side effects in young children, according to a stu...
CureVac Stock Just Got Upgraded. It’s Now a Competitor in mRNA Vaccines.
CureVac is ready to compete in the big leagues with its vaccines, according to a UBS analyst who says the soaring stock has more room to rise. UBS analyst Eliana Merle upgraded the shares (ticker: CVA...
One of Wall Street’s biggest bulls last year says he’s learned his lesson and isn’t chasing stocks right now
The young new year has been all about reversion to the mean. Take the ARK Innovation ETF ARKK, -2.94% — Cathie Wood’s flagship fund of mostly unprofitable tech companies has stormed 19% higher in 2023...
Dow drops over 600 points, posts worst day of year after weak economic data, hawkish Fed remarks erase inflation cheer
U.S. stock indexes finished sharply lower on Wednesday, with both the Dow Jones Industrial Average and the S&P 500 index booking their worst day in over a month, after data on falling retail sales...
Chinese travelers ready to flock overseas for Western mRNA vaccines
Passengers prepare to enter Shenzhen through the Lok Ma Chau Spur Line Control Point on the first day of the resumption of normal travel between Hong Kong and mainland China on Jan. 8, 2023, in Hong K...
Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September
Topline Trials of cutting-edge cancer vaccines could kick off in the U.K. as soon as September, German Covid vaccine maker BioNTech announced on Friday, part of a new government partnership to fast tr...
Why a Long-Term Investor Is Sticking With Tesla and Cloud Shares
Everything about the investment approach at Baillie Gifford screams patience. Founded more than 110 years ago, the Scottish portfolio management firm, which oversees $250 billion, is a believer in the...
CytomX shares surge more than 50% on Moderna partnership
CytomX Therapeutics Inc. CTMX, +7.19% shares soared more than 50% in the extended session Thursday after the small biotech company announced a partnership with Moderna Inc. MRNA, -2.17% CytomX shares ...
Where Are All The Scientific Breakthroughs? Forget AI, Nuclear Fusion And mRNA Vaccines, Advances In Science And Tech Have Slowed, Major Study Says
Topline Despite surges in fields like AI, medicine and nuclear energy, major advances in science and technology are slowing and are fewer and farther between than decades ago, according to a study pub...
BioNTech MRNA Vaccine Approved In Hong Kong, Week In Review
Week in Review Asian equities started the week lower as the Bank of Japan unexpectedly raised its yield ceiling on government bonds, but gained some ground later in the week as Hong Kong outperformed....
Moderna (MRNA) Q3 earnings 2022
A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, September 8, 2022. Ha...
MRNA Stock Surges On Upgrade As Commercial Covid Market Opens
Moderna (MRNA) snagged an upgrade Friday on the likelihood it will follow in Pfizer‘s (PFE) footsteps in hiking the price of its Covid vaccine in 2023. MRNA stock jumped on the news. X Pfizer pl...
Moderna Stock Takes Off on Cancer Vaccine News
Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will pay Moderna (MRNA) $250 million for...
Moderna Stock Surges. China Would Be a Big Market.
Text size Moderna stock has gotten a boost from the CEO’s comments about China. Photo by Justin Sullivan/Getty Images Moderna ’s Covid-19 vaccine has been wildly successful, but its stock has be...
The Oil Surplus Could Persist. Expect Prices to Fall
Text size This commentary was issued recently by money managers, research firms, and market newsletter writers and has been edited by Barron’s. Expect Oil Prices to Fall THINK Economic and Finan...
What Stocks Are Making Moves Monday? Li Auto, NIO, Peloton, and More.
Text size A trader works on the floor of the New York Stock Exchange. Michael Nagle/Bloomberg Stock futures were trading lower Monday after China cut interest rates following data that showed the worl...
10 Companies That Would Pay More Taxes Under Inflation Reduction Act
Text size Packages ready to be sent at an Amazon center. Thomas Samson/AFP via Getty Images Some major companies, including Tesla and Amazon . com, are likely to face higher tax bills under the $750 b...
Not Your Hot-Tip-From-Your-Brother-In-Law Biotech Stock
Better-than-expected Covid-19 vaccine sales pushed Moderna past Wall Street’s 2022 second-quarter … [+] forecasts. The company said Wednesday, Aug. 3, 2022, that its Spikevax vaccine brought in ...
Covid mRNA Vaccines Safe For Pregnant People, New Study Reinforces
Topline In a finding that provides more reassurance of the safety of Covid-19 messenger RNA vaccines for pregnant people, a Canadian study found pregnant women—who are at higher risk for more severe c...
Moderna CEO: No ‘Crazy’ Deals. We’re Giving Cash to Shareholders.
Text size Moderna CEO Stephane Bancel says his company will keep returning cash to investors until it finds a better way of creating value. Jason Alden/Bloomberg Moderna ’s CEO is feeling no pressure ...
Moderna (MRNA) Q2 2022
Illustration of a vial of Moderna vaccine for coronavirus treatment. Marcos Del Mazo | Lightrocket | Getty Images Moderna on Wednesday reported second quarter results that beat earnings and revenue ex...
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...